Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Arcturus, Astrazeneca, Boehringer Ingelheim, Bridge, Capricor, Crescita, Generex, GPCR, Humanigen, Juyou, Metriopharm, Neoleukin, Novavax, Om, Ose Immunotherapeutics, Qualigen, Sichuan Clover, Taigen, Taiwan Liposome, Vir, Wuxi Apptec.